About Hampsbio
Hampsbio is a company. The company has 34 employees as of March 28, 2024. Hampsbio offers products and services including Pharmaceutical Formulations and Freeze-Dried Ingredients.
- Employees 34 as on 28 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hamps Bio Ltd.
-
Annual Revenue
$780.61 K (USD)2.99as on Mar 31, 2025
-
Net Profit
$34.88 K (USD)-40.53as on Mar 31, 2025
-
EBITDA
$90.01 K (USD)-34.65as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
34
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hampsbio
Hampsbio is a publicly listed company on the BSE with ticker symbol HAMPS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Hampsbio
Hampsbio offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Freeze-Dried Ingredients.
Various medicines and formulations are manufactured and distributed for therapeutic purposes, covering areas like anti-hypertensive and antibiotics
Freeze-dried fruits, vegetables, and herbs are supplied for use in industries such as tea, soup, and nutrition bars, serving B2B and B2C markets
Funding Insights of Hampsbio
Investments & Acquisitions by Hampsbio
Financial Statements - Hampsbio
Hampsbio Comparisons
Competitors of Hampsbio
Latest news on Hampsbio
Frequently Asked Questions about Hampsbio
As of Mar 28, 2024, the latest employee count at Hampsbio is 34.
Annual revenue of Hampsbio is $780.61K as on Mar 31, 2025.
Operations in the pharmaceutical and food sectors are conducted by Hampsbio, where tablets, capsules, syrups, and injectables are produced alongside freeze-dried fruits, vegetables, herbs, and other ingredients. These products are supplied to business-to-business and business-to-consumer markets, both domestically and internationally. Branded items for direct consumer purchase are also offered, supporting diverse applications in health and nutrition.
Hampsbio offers Pharmaceutical Formulations and Freeze-Dried Ingredients.
Yes, Hampsbio is publicly traded on BSE under the ticker symbol HAMPS.
The ticker symbol of Hampsbio is HAMPS on BSE.